Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Ali Hosni, Kathy Han, Lisa W. Le, Jolie Ringash, James Brierley, Rebecca Wong, Robert Dinniwell, Anthony Brade, Laura A. Dawson, Bernard J. Cummings, Monika K. Krzyzanowska, Eric X. Chen, David Hedley, Jennifer Knox, Alexandra M. Easson, Patricia Lindsay, Tim Craig, John Kim
Published Apr 17, 2018 · Vol. 9, No. 29 · pp. 20439-20450
Kari Trumpi, Nicola Frenkel, Timo Peters, Nicoline M. Korthagen, Jennifer M.J. Jongen, Daniëlle Raats, Helma van Grevenstein, Yara Backes, Leon M. Moons, Miangela M. Lacle, Jan Koster, Danny Zwijnenburg, Inne H.M. Borel Rinkes, Onno Kranenburg
Published Apr 13, 2018 · Vol. 9, No. 28 · pp. 19490-19507
Rositsa G. Koleva-Kolarova, Marcel J.W. Greuter, Talitha L. Feenstra, Karin M. Vermeulen, Erik F.J. de Vries, David Parkin, Erik Buskens, Geertruida H. de Bock
Published Apr 13, 2018 · Vol. 9, No. 28 · pp. 19836-19846
